Table 1.
Patient demographics and characteristics in the PH cohorts
| Overall N=24,470 |
PH (mPAP >20 mm Hg or TRV >3.4 m/s), N = 5016 |
Pre-capillary PH (by RHC only) N=701 |
Group 1 PH - PAH (mPAP >20 mm Hg + 1 PAH-medication) N=572 |
Group 3 PH – PH due to lung disease and/or hypoxia (mPAP >20 mm Hg + 1 qualifying ICD code) N=958 |
|
|---|---|---|---|---|---|
| Male gender, n (%) | 12,257 (50.1) | 2650 (52.8) | 296 (42.2) | 237 (41.4) | 562 (58.7) |
| Female gender, n (%)* | 12,206 (49.9) | 2366 (47.2) | 405 (57.8) | 335 (58.6) | 396 (41.3) |
| Mean (SD) age, years | 62.3 (17.6) | 65.3 (16.8) | 58.4 (14.5) | 55.0 (14.6) | 62.5 (12.4) |
| Race, n | |||||
| White | 13,194 (53.9) | 1586 (31.6) | 235 (33.5) | 292 (51.0) | 553 (57.7) |
| Black/African American | 2084 (8.5) | 425 (8.5) | 51 (7.3) | 72 (12.6) | 132 (13.8) |
| Asian | 4309 (17.6) | 521 (10.4) | 59 (8.4) | 77 (13.5) | 97 (10.1) |
| Native Hawaiian/Pacific Islander | 362 (1.5) | 69 (1.4) | 7 (1.0) | 9 (1.6) | 12 (1.3) |
| Unknown | 4521 (18.5) | 2,415 (48.1) | 349 (49.8) | 122 (21.3) | 164 (17.1) |
*
7 individuals identified as non-binary gender, hence the percentages do not total 100.